Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
 
GST on expired and damaged stocks costs pharma Rs 500 crore a year

Why should there be the Goods and Services Tax on materials that cannot be sold? That is the question, the Indian pharmaceutical industry, is hoping will get addressed in the final tweaking of the GST provisions.

Advertisement